Insider Transactions in Q1 2024 at Chimerix Inc (CMRX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 14
2024
|
David Jakeman VP OF FINANCE AND ACCOUNTING |
SELL
Open market or private sale
|
Direct |
2,660
-1.85%
|
$2,660
$1.04 P/Share
|
|
Feb 14
2024
|
Michelle La Spaluto CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,940
-1.72%
|
$1,940
$1.04 P/Share
|
|
Feb 14
2024
|
Michael T. Andriole PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct |
1,744
-0.39%
|
$1,744
$1.04 P/Share
|
|
Feb 01
2024
|
Michael Albert Alrutz SVP AND GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
21,875
+11.51%
|
-
|
|
Feb 01
2024
|
Michelle La Spaluto CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+18.12%
|
-
|
|
Feb 01
2024
|
Allen S. Melemed CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
28,125
+24.55%
|
-
|
|
Feb 01
2024
|
Michael T. Andriole PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
83,750
+15.73%
|
-
|
|
Feb 01
2024
|
David Jakeman VP OF FINANCE AND ACCOUNTING |
BUY
Grant, award, or other acquisition
|
Direct |
10,750
+6.95%
|
-
|